MMP14 and central nervous system cancer: M2 TAMs enhance glioma invasion via TLR2-induced matrix metalloproteinase-14 (MMP-14)/MMP-2 expression and support GSC proliferation [38], epithelial–mesenchymal transition (EMT), and therapy resistance.